ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,261.80
0.50%
S&P ASX All Technology
3,859.50
0.90%
Brent Oil
73.44
0.00%
US Dollar vs AUD
1.60875
-0.08%
Bitcoin
94,861.75
0.74%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. Merck KGAA (MRK) Share Price

Merck KGAA

Merck KGAA (MRK)

Marks Electrical Group Plc
Merck and Co Inc
139.90
1.80
(1.30%)
Closed 29 December 8:00AM
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
139.90
Bid
139.10
Offer
140.65
Volume
4,553
137.10 Day's Range 140.75
136.15 52 Week Range 176.90
Market Cap
18.081B
Previous Close
138.10
Open
137.15
Last Trade
6
@
139.94999
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
9,222
Shares Outstanding
129,242,251
Dividend Yield
1.57%
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
20.99B
Net Profit
2.82B

About Merck KGAA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Diversified
Website
www.merck.de
Headquarters
Darmstadt, Deu
Founded
1987
Merck KGAA is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker MRK. The last closing price for Merck KGAA was 138.10 €. Over the last year, Merck KGAA shares have traded in a share price range of 136.15 € to 176.90 €.

Merck KGAA currently has 129,242,251 shares in issue. The market capitalisation of Merck KGAA is 17.85 € billion.

Ask ADVFN Intelligence (AI)

MRK Latest News

More News

Imugene Announces Clinical Trial Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate HER-Vaxx in Combination with Avelumab for Treatment of Gastric Cancer

New clinical trial supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc.Avelumab (BAVENCIO®) to be provided to Imugene for Phase 2 clinical study in HER-2 positive gastric or...

17 November 2021
GlobeNewswire Inc.

Putting the Patient First: Merck Serono to Present Data That Embodies the ESMO 2014 Theme of 'Precision Medicine in Cancer Ca...

Putting the Patient First: Merck Serono to Present Data That Embodies the ESMO 2014 Theme of 'Precision Medicine in Cancer Care' PR Newswire DARMSTADT, Germany, September 26, 2014 DARMSTADT...

26 September 2014
PR Newswire (US)

Merck Serono Awards Grant for Growth Innovation (GGI) for the First Time

Merck Serono Awards Grant for Growth Innovation (GGI) for the First Time PR Newswire DARMSTADT, Germany, September 19, 2014 DARMSTADT, Germany, September 19, 2014 /PRNewswire/ -- The first grants...

19 September 2014
PR Newswire (US)

Merck Announces Detailed 26-Week Results from Phase IIIb Study with Kuvan in Children with PKU Below 4 Years of Age

Merck Announces Detailed 26-Week Results from Phase IIIb Study with Kuvan in Children with PKU Below 4 Years of Age PR Newswire DARMSTADT, Germany, September 3, 2014 DARMSTADT, Germany, September...

03 September 2014
PR Newswire (US)

Merck Serono Announces Groundbreaking of New Pharmaceutical Manufacturing Facility in China, its Second Largest Worldwide

Merck Serono Announces Groundbreaking of New Pharmaceutical Manufacturing Facility in China, its Second Largest Worldwide PR Newswire NANTONG, China, August 27, 2014 NANTONG, China, August 27...

27 August 2014
PR Newswire (US)

Merck Serono Announces FDA Clearance for Auxogyn's Early Embryo Viability Assessment (Eeva®) System

Merck Serono Announces FDA Clearance for Auxogyn's Early Embryo Viability Assessment (Eeva®) System PR Newswire DARMSTADT, Germany, June 10, 2014 DARMSTADT, Germany, June 10, 2014 /PRNewswire/...

10 June 2014
PR Newswire (US)

EMD Serono to Release New Pipeline Data at ASCO 2014 from Early-Stage Investigational Compounds in Difficult-to-Treat Cancers

EMD Serono to Release New Pipeline Data at ASCO 2014 from Early-Stage Investigational Compounds in Difficult-to-Treat Cancers PR Newswire ROCKLAND, Massachusetts, May 29, 2014 ROCKLAND...

29 May 2014
PR Newswire (US)

Merck Serono's President & CEO Belén Garijo has Been Appointed to Board of Directors of L'Oréal

Merck Serono's President & CEO Belén Garijo has Been Appointed to Board of Directors of L'Oréal PR Newswire DARMSTADT, Germany and PARIS, April 17, 2014 DARMSTADT, Germany and PARIS, April...

18 April 2014
PR Newswire (US)

European Commission Approves Update of Erbitux Metastatic Colorectal Cancer Labeling to Patients With RAS Wild-Type Tumors

European Commission Approves Update of Erbitux Metastatic Colorectal Cancer Labeling to Patients With RAS Wild-Type Tumors PR Newswire DARMSTADT, Germany, December 23, 2013 DARMSTADT, Germany...

23 December 2013
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
12.31.67151162791137.6140.75136.157776138.13708848DE
4-0.95-0.674476393326140.85146.19999136.1510001140.91240732DE
12-17.25-10.976773783157.15168.1136.159222147.91261027DE
26-14.6-9.4498381877154.5176.9136.157528154.07893268DE
52-2.04999-1.44416353957141.94999176.9136.158255154.6309127DE
156-85-37.7945753668224.9231.5134.35180571173.47582402DE
26034.132.2306238185105.8231.576.22290890148.20524592DE

MRK - Frequently Asked Questions (FAQ)

What is the current Merck KGAA share price?
The current share price of Merck KGAA is 139.90 €
How many Merck KGAA shares are in issue?
Merck KGAA has 129,242,251 shares in issue
What is the market cap of Merck KGAA?
The market capitalisation of Merck KGAA is EUR 17.85B
What is the 1 year trading range for Merck KGAA share price?
Merck KGAA has traded in the range of 136.15 € to 176.90 € during the past year
What is the reporting currency for Merck KGAA?
Merck KGAA reports financial results in EUR
What is the latest annual turnover for Merck KGAA?
The latest annual turnover of Merck KGAA is EUR 20.99B
What is the latest annual profit for Merck KGAA?
The latest annual profit of Merck KGAA is EUR 2.82B
What is the registered address of Merck KGAA?
The registered address for Merck KGAA is FRANKFURTER STRASSE 250, DARMSTADT, 64293
What is the Merck KGAA website address?
The website address for Merck KGAA is www.merck.de
Which industry sector does Merck KGAA operate in?
Merck KGAA operates in the PHARMACEUTICAL DIVERSIFIED sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
Z4UreAlpha Tech Corp
2.60 €
(114.70%)
8.05k
510Graphex Group Limited
0.392 €
(106.32%)
16.46k
34Q0Quantum eMotion Inc
0.73 €
(103.91%)
2.99M
M000Vertical Aerospace Ltd
14.50 €
(101.39%)
8.16k
2WOWide Open Agriculture Ltd
0.01 €
(100.00%)
18k
ANLAnalog Devices Inc
9.6728 €
(-95.32%)
1.25k
E3O1Nexoptic Technology Corp
0.007 €
(-62.16%)
12.62k
WWTWater Ways Technologies Inc
0.003 €
(-50.00%)
181.5k
1RR1Rokmaster Resources Corp
0.006 €
(-50.00%)
19k
7CCCheckCap Ltd
1.14 €
(-47.22%)
265
PF8European Lithium Limited
0.024 €
(18.81%)
14.01M
D7GNel ASA
0.2429 €
(-3.07%)
5.39M
RQ0DWave Quantum Inc
9.474 €
(21.03%)
3.1M
34Q0Quantum eMotion Inc
0.73 €
(103.91%)
2.99M
M11First Graphene Limited
0.019 €
(4.40%)
2.5M

Discussion

View Full Feed
Scotttrader80 Scotttrader80 2 minutes ago
TSLY $1.28 this month https://www.globenewswire.com/news-release/2024/12/26/3001920/0/en/YieldMax-ETFs-Announces-Distributions-on-TSLY-1-2860-TSMY-0-8065-YBIT-0-7088-YMAX-0-2448-YMAG-0-1742-and-Others.html
TSLY
NASDAQ2020 NASDAQ2020 2 minutes ago
Do you know IMS market size of Focalin XR ?
ELTP
Smartypants2 Smartypants2 2 minutes ago
I've provided numerous references of the courts voiding the loans. Why doin't you cite recent cases in which toxic lenders (who you strangely choose to side with) have prevailed against the Basile Law Firm?
XERI
bobby1151 bobby1151 3 minutes ago
You are correct - Keep your great posts coming!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
BIEL
Chartmaster Chartmaster 3 minutes ago
Sweet 9's close for a Friday!!! Brace yourselves for 2025 OTC Gold rush, just like 2021 imo
GRLT
Hestheman47 Hestheman47 3 minutes ago
From your lips to God's ears. A new SEC Chairman is in the works soon. I would love to see the so- called "expert market" ended, and for the over 3k stocks on that market opened up to retail to trade. The more opportunities the better. Rollback the regulations that were implemented in 2019/2020 (ame
SYIN
NASDAQ2020 NASDAQ2020 3 minutes ago
I don't remember Nasrat putting a name on it.
I believe Weizel may have came up with it based on IMS # s
ELTP
doc2016 doc2016 4 minutes ago
confused on the patent discussions? try:https://notebooklm.google/

you can have them create a podcast type of presentation ..like upload the justia address for ionq or nvidia patents.. i tried a query how could nvidia and ionq be used together?

amazing.
IONQ
cojoboy cojoboy 5 minutes ago
Well.child..This fool makes a lot of money..flipping. And holding..and it ain't going anywhere..but in my bank accounts..😎😎😎😎😎
IGPK
JamesF1 JamesF1 6 minutes ago
Thanks Jour, maybe Focalin XR is the drug if it’s not Concerta. Whatever it is, it would be a positive if a successful study is announced.
ELTP
infamous infamous 6 minutes ago
What? Those were options given. Bs
AMD
STL Stock STL Stock 6 minutes ago
Im not scoffing. I've seen this type of thing go down before. $0.07-$0.30 rise in share price before any actual adjustments to share structure is my guess. Ppl will want to get as many shares as possible for any potential swap/exchange. Inevitably driving up share price.
HMBL
Porterhouse10 Porterhouse10 6 minutes ago
Still losing money Ehhh
ASII
ZenDomain85 ZenDomain85 6 minutes ago
If China goes to war with the U.S. - that means also going to war with Australia and Japan, Taiwan, South Korea, Indonesia, NATO allies, India and list goes on. Where would they sell their goods? Would average Chinese citizen be onboard with this? I would see a political upheaval as more likely i
FFMGF
Chartmaster Chartmaster 7 minutes ago
BLUE SKY BREAKOUT ALERT!!!
AAGC
mike_dotcom mike_dotcom 7 minutes ago
I still own most of what I bought back in 2019. The real question is why are you here? You still mad that the model called you ugly and spurned your lude advances? You're not classy enough for her anyway. I'm kind of glad you're sticking around though just so we can all rub your nose in the succ
AVXL
Porterhouse10 Porterhouse10 7 minutes ago
John Kent says patience pays JMO
GDVM
Johnnycombat10 Johnnycombat10 7 minutes ago
The only logical conclusion for funding by investors to PHIL is that Phil has the written agreements within Vietnam and elsewhere to facilitate the development of all the ideas and technologies for which Phil is the conduit to achieve the projects. These agreements are the basis for the investments
PHIL
Monksdream Monksdream 8 minutes ago
WKEY, 10 day hourly
https://investorshub.advfn.com/uimage/uploads/2024/12/28/lodobIMG_4271.gif
WKEY
gitreal gitreal 8 minutes ago
I can't wait for the stories he'll spin to sell those shares. Hopefully they show some imagination.

Mt. Vernon Mine and Bishop Mill still listed as "abandoned" by MSHA. Is he gonna keep lying about that?
NBRI
JMMatthews JMMatthews 8 minutes ago
Very nice call here

IVDA $$$
IVDA
na na na na 8 minutes ago
https://i.imgur.com/FWQoUMn.png
THBD
infamous infamous 8 minutes ago
Oh jeez. Here comes the otc like pumping. Smh
AMD
Myth Myth 9 minutes ago
from what I heard Chalamet did an outstanding job portraying Dylan, on my bucket list for sure !

Thx...

Your Recent History

TG
MRK
Merck KGAA
NYSE
HIX
Western Asset High Incom...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads